All information about the ABROAD research trial
Signs and symptoms of Alzheimer’s disease
Signs and symptoms of mild Alzheimer’s disease can be varied but noticeable and affect memory, behavior and thinking ability:
- Difficulty in storing new information
- Forgetfulness such as “paying bills”.
- Frequent misplacement of objects
- Forgetting appointments or important dates
- Difficulty in paying attention to something or someone
All these symptoms can, over time, increase and multiply, becoming a problem in your daily activity.
In the Neurology Service we currently have a research trial, for patients who already have a diagnosis of mild Alzheimer’s disease or who are experiencing signs and symptoms compatible with the disease.
Requirements for participation in the research trial
- You must be between 50 and 90 years old
- Bediagnosed with or have compatible signs and symptoms.
- Being able to count on a “rehearsal partner” who should be with you an average of 10 hours a week
During your participation in the trial, medical care, visits, examinations and trial-related drugs would be free of charge. Travel expenses may also be covered.
What does the ABROAD research trial consist of?
- Two visits at the trial medical center to determine if you are a candidate for participation
- Once selected, you are randomly assigned to either the drug group or the placebo group (the placebo looks like the trial drug but has no active ingredient).
- The probability of receiving the investigational drug is 75%.
- Neither patients nor investigators will know whether drug or placebo is administered
- The drug will be administered orally for 12 weeks.
- The full duration of the trial is approximately 20 weeks: 8 visits to the medical center for tests and evaluations and 4 telephone appointments with the investigating physician.
Benefits and risks of your participation
The results could benefit research into this disease.
Side effects may be experienced
All known risks and side effects associated with the trial are reviewed with the patient prior to participation.
During the trial, rigorous monitoring will be carried out to detect any side effects and any health changes
